Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pediatric Primary Pulmonary Hypertension.

Andrew J. Maxwell1, Nancy D. Bridges

  • 1Pediatric Pulmonary Hypertension Program, Mount Sinai Medical Center, One Gustave L. Levy Place, Box 1201, New York, NY 10029, USA.

Current Treatment Options in Cardiovascular Medicine
|August 31, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fenestration of the Fontan baffle: Benefits and complications.

Seminars in thoracic and cardiovascular surgery. Pediatric cardiac surgery annual·2001
Same author

Aortic insufficiency: Indications for surgery in children.

Seminars in thoracic and cardiovascular surgery. Pediatric cardiac surgery annual·2001
Same author

Surgical management of congenital and acquired pulmonary vein stenosis.

Seminars in thoracic and cardiovascular surgery. Pediatric cardiac surgery annual·2001
Same journal

An Update on the Role of Renal Artery Denervation in the Treatment of Hypertension.

Current treatment options in cardiovascular medicine·2026
Same journal

Advancements and Challenges in Contemporizing Care for Adult Patients with Congenital Heart Disease and Advanced Heart Failure: An Update on Application of Modern Heart Failure Technologies.

Current treatment options in cardiovascular medicine·2026
Same journal

Evolving Decongestion Strategies in the Management of Acute Heart Failure.

Current treatment options in cardiovascular medicine·2025
Same journal

Advanced Electroanatomic Mapping: Current and Emerging Approaches.

Current treatment options in cardiovascular medicine·2025
Same journal

Metabolic Reprogramming in Heart Failure: From Energy Starvation to Therapeutic Targets.

Current treatment options in cardiovascular medicine·2025
Same journal

Drug-Coated Balloons for Coronary Artery Disease: From Theory to Practice.

Current treatment options in cardiovascular medicine·2025
See all related articles

Primary pulmonary hypertension (PPH) lacks a single best therapy, but available treatments improve quality of life and prolong survival. Treatment involves a stepwise approach, prioritizing palliative care before considering organ replacement.

Area of Science:

  • Cardiology
  • Pulmonology
  • Pharmacology

Background:

  • Primary pulmonary hypertension (PPH) is a progressive, life-limiting disease.
  • Current therapeutic options for PPH are palliative, not curative, and carry significant side effects.
  • Despite limitations, available therapies are crucial for improving patient quality of life and survival.

Purpose of the Study:

  • To outline a hierarchical approach to managing primary pulmonary hypertension.
  • To guide clinicians in selecting optimal therapeutic regimens based on disease progression.
  • To emphasize the importance of palliative care and judicious use of advanced therapies.

Main Methods:

  • Review of current literature on primary pulmonary hypertension management.
  • Development of a tiered therapeutic strategy based on efficacy and morbidity.

Related Experiment Videos

  • Inclusion of established and emerging treatment modalities.

    • Main Results:

    • A recommended hierarchy of therapy for PPH is presented, starting with supportive care and progressing to advanced interventions.
    • The hierarchy includes anticongestive therapy, anticoagulation, oxygen, calcium channel blockers, prostacyclin, beta-agonists, and lung transplantation.
    • Organ replacement is reserved for end-stage disease after failure of all other treatments.

    Conclusions:

    • Effective management of PPH requires a tailored, stepwise therapeutic approach.
    • Palliative therapies significantly improve quality of life and prolong survival in PPH patients.
    • Emerging therapies are expected to further refine PPH treatment strategies in the future.